JNCE - Jounce Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

JNCE is currently covered by 6 analysts with an average price target of $4.65. This is a potential upside of $4.65 (0%) from yesterday's end of day stock price of $0.

Jounce Therapeutics's activity chart (see below) currently has 26 price targets and 31 ratings on display. The stock rating distribution of JNCE is 66.67% BUY and 33.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 15.63% with an average time for these price targets to be met of 262 days.

Highest price target for JNCE is $8, Lowest price target is $1, average price target is $4.65.

Most recent stock forecast was given by MICHAEL ULZ from MORGAN STANLEY on 28-Mar-2023.

Currently out of the existing stock ratings of JNCE, 8 are a BUY (66.67%), 4 are a HOLD (33.33%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$0.12 (6.38%)

7

1 years ago

0/4 (0%)

$0.16 (8.70%)

Hold

3

1 years 1 months 5 days ago

2/8 (25%)

$1.82 (154.24%)

622

Buy

5

$3.12 (165.96%)

9

1 years 2 months 25 days ago

0/4 (0%)

$3.91 (358.72%)

Buy

11

$9.12 (485.11%)

15

1 years 7 months 23 days ago

0/2 (0%)

$6.84 (164.42%)

Buy

15

$13.12 (697.87%)

15

1 years 10 months 16 days ago

0/4 (0%)

$10.75 (252.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JNCE (Jounce Therapeutics) average time for price targets to be met?

On average it took 262 days on average for the stock forecasts to be realized with a an average price target met ratio 15.63

Which analyst has the current highest performing score on JNCE (Jounce Therapeutics) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the current lower performing score on JNCE (Jounce Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the most public recommendations on JNCE (Jounce Therapeutics)?

Steven Seedhouse works at RAYMOND JAMES and has 18 price targets and 16 ratings on JNCE

Which analyst is the currently most bullish on JNCE (Jounce Therapeutics)?

Zegbeh Jallah with highest potential upside - $13.12

Which analyst is the currently most reserved on JNCE (Jounce Therapeutics)?

Steven Seedhouse with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?